A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain
2006

A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain

publication Evidence: moderate

Author Information

Author(s): Levinson Nicholas M, Kuchment Olga, Shen Kui, Young Matthew A, Koldobskiy Michael, Karplus Martin, Cole Philip A, Kuriyan John

Primary Institution: University of California Berkeley

Hypothesis

The study investigates the structural variations of the Abl tyrosine kinase domain and their implications for drug resistance in chronic myeloid leukemia.

Conclusion

The Abl kinase domain can adopt a Src-like inactive conformation, which may contribute to imatinib resistance.

Supporting Evidence

  • The study presents new crystal structures of the Abl kinase domain that reveal conformational variability.
  • Mutations in the BCR–Abl kinase domain can destabilize the inactive Src-like conformation, impacting imatinib binding.
  • Imatinib binds with high affinity to the flipped DFG conformation of Abl, which is not present in Src kinases.

Takeaway

Scientists found that a protein involved in cancer can change its shape in a way that helps it resist treatment. This shape is similar to another protein that doesn't respond to the same treatment.

Methodology

The study utilized crystallographic studies and molecular dynamics simulations to analyze the conformations of the Abl kinase domain.

Limitations

The study primarily focuses on the isolated kinase domain, which may not fully represent the behavior of the full-length protein in cellular contexts.

Digital Object Identifier (DOI)

10.1371/journal.pbio.0040144

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication